https://european-biotechnology.net/wp-content/uploads/2026/01/Biontech-Geba__ude.jpg540960Thomas Gabrielczyk/wp-content/uploads/2019/12/ebn-1-300x135.pngThomas Gabrielczyk2026-02-24 11:40:372026-02-24 11:40:37Early BioNTech mRNA breast cancer trial delivers surprise in longtime disease control
https://european-biotechnology.net/wp-content/uploads/2026/02/alex-shuper-IOusOQundeI-unsplash.jpg427640Thomas Gabrielczyk/wp-content/uploads/2019/12/ebn-1-300x135.pngThomas Gabrielczyk2026-02-24 09:13:232026-02-24 09:13:23Angelini partners with Quiver on AI-driven discovery in genetic epilepsies
https://european-biotechnology.net/wp-content/uploads/2026/02/getty-images-dOsfaqxn81M-unsplash-1030x706-1.jpg7061030Thomas Gabrielczyk/wp-content/uploads/2019/12/ebn-1-300x135.pngThomas Gabrielczyk2026-02-23 14:01:452026-02-23 14:01:45Syndex Bio raises $15.5M seed and unveils mcPCR platform for DNA methylation analysis
https://european-biotechnology.net/wp-content/uploads/2025/11/Alzheimer_semaglutide_483897781_059ZuRgXrKJ8ubHxTiCeiYY6BOdGSl4Z-e1764149601345.jpg433653Thomas Gabrielczyk/wp-content/uploads/2019/12/ebn-1-300x135.pngThomas Gabrielczyk2026-02-20 13:38:412026-02-20 13:38:41J&J stops enrollment in an AC Immune-partnered Alzheimer trial, but the reason is not yet clear
https://european-biotechnology.net/wp-content/uploads/2026/02/resource-database-4uUmTpyb5eU-unsplash-1-1030x579-1.jpg5791030Thomas Gabrielczyk/wp-content/uploads/2019/12/ebn-1-300x135.pngThomas Gabrielczyk2026-02-18 16:56:022026-02-18 16:56:02PLL Therapeutics reports positive phase I/II data for gut-targeting ALS therapy
